Skip to main content
    • Aa
    • Aa
  • Get access
    Check if you have access via personal or institutional login
  • Cited by 38
  • Cited by
    This article has been cited by the following publications. This list is generated based on data provided by CrossRef.

    Lam, Raymond W. 2012. Onset, time course and trajectories of improvement with antidepressants. European Neuropsychopharmacology, Vol. 22, p. S492.

    Helmreich, Isabella and Tadić, André 2012. Große Wirkung in kleiner Gruppe?. InFo Neurologie & Psychiatrie, Vol. 14, Issue. 4, p. 18.

    Korf, Jakob 2014. Delayed mood transitions in major depressive disorder. Medical Hypotheses, Vol. 82, Issue. 5, p. 581.

    Keers, Robert and Aitchison, Katherine J 2011. Pharmacogenetics of antidepressant response. Expert Review of Neurotherapeutics, Vol. 11, Issue. 1, p. 101.

    Joesch, Jutta M. Golinelli, Daniela Sherbourne, Cathy D. Sullivan, Greer Stein, Murray B. Craske, Michelle G. and Roy-Byrne, Peter P. 2013. TRAJECTORIES OF CHANGE IN ANXIETY SEVERITY AND IMPAIRMENT DURING AND AFTER TREATMENT WITH EVIDENCE-BASED TREATMENT FOR MULTIPLE ANXIETY DISORDERS IN PRIMARY CARE. Depression and Anxiety, Vol. 30, Issue. 11, p. 1099.

    Smits, Dave Stinckens, Nele Luyckx, Koen and Claes, Laurence 2015. Early symptom change in adult outpatients: Relationship with patient characteristics and therapeutic alliance. Psychology and Psychotherapy: Theory, Research and Practice, p. n/a.

    Broen, M.P.G. Leentjens, A.F.G. Köhler, S. Kuijf, M.L. McDonald, W.M. and Richard, I.H. 2016. Trajectories of recovery in depressed Parkinson's disease patients treated with paroxetine or venlafaxine. Parkinsonism & Related Disorders, Vol. 23, p. 80.

    Hybels, Celia F. Pieper, Carl F. Blazer, Dan G. and Steffens, David C. 2016. Heterogeneity in the three-year course of major depression among older adults. International Journal of Geriatric Psychiatry, Vol. 31, Issue. 7, p. 775.

    Tansey, Katherine E. Guipponi, Michel Domenici, Enrico Lewis, Glyn Malafosse, Alain O'Donovan, Michael Wendland, Jens R. Lewis, Cathryn M. McGuffin, Peter and Uher, Rudolf 2014. Genetic susceptibility for bipolar disorder and response to antidepressants in major depressive disorder. American Journal of Medical Genetics Part B: Neuropsychiatric Genetics, Vol. 165, Issue. 1, p. 77.

    Wardenaar, Klaas J. Conradi, Henk-Jan and de Jonge, Peter 2014. DATA-DRIVEN COURSE TRAJECTORIES IN PRIMARY CARE PATIENTS WITH MAJOR DEPRESSIVE DISORDER. Depression and Anxiety, Vol. 31, Issue. 9, p. 778.

    Doyle, O. M. Tsaneva-Atansaova, K. Harte, J. Tiffin, P. A. Tino, P. and Diaz-Zuccarini, Vanessa 2013. Bridging Paradigms: Hybrid Mechanistic-Discriminative Predictive Models. IEEE Transactions on Biomedical Engineering, Vol. 60, Issue. 3, p. 735.

    Bares, Martin Novak, Tomas Kopecek, Miloslav Brunovsky, Martin Stopkova, Pavla and Höschl, Cyril 2015. The effectiveness of prefrontal theta cordance and early reduction of depressive symptoms in the prediction of antidepressant treatment outcome in patients with resistant depression: analysis of naturalistic data. European Archives of Psychiatry and Clinical Neuroscience, Vol. 265, Issue. 1, p. 73.

    Schennach, Rebecca Meyer, Sebastian Seemüller, Florian Jäger, Markus Schmauss, Max Laux, Gerd Pfeiffer, Herbert Naber, Dieter Schmidt, Lutz G. Gaebel, Wolfgang Klosterkötter, Joachim Heuser, Isabella Maier, Wolfgang Lemke, Matthias R. Rüther, Eckart Klingberg, Stefan Gastpar, Markus Musil, Richard Möller, Hans-Jürgen and Riedel, Michael 2012. Response trajectories in “real-world” naturalistically treated schizophrenia patients. Schizophrenia Research, Vol. 139, Issue. 1-3, p. 218.

    Uher, R. Carver, S. Power, R. A. Mors, O. Maier, W. Rietschel, M. Hauser, J. Dernovsek, M. Z. Henigsberg, N. Souery, D. Placentino, A. Farmer, A. and McGuffin, P. 2012. Non-steroidal anti-inflammatory drugs and efficacy of antidepressants in major depressive disorder. Psychological Medicine, Vol. 42, Issue. 10, p. 2027.

    Uher, Rudolf Dernovsek, Mojca Zvezdana Mors, Ole Hauser, Joanna Souery, Daniel Zobel, Astrid Maier, Wolfgang Henigsberg, Neven Kalember, Petra Rietschel, Marcella Placentino, Anna Mendlewicz, Julien Aitchison, Katherine J. McGuffin, Peter and Farmer, Anne 2011. Melancholic, atypical and anxious depression subtypes and outcome of treatment with escitalopram and nortriptyline. Journal of Affective Disorders, Vol. 132, Issue. 1-2, p. 112.

    Castellani, Valeria Pastorelli, Concetta Eisenberg, Nancy Gerbino, Maria Di Giunta, Laura Ceravolo, Rosalba and Milioni, Michela 2014. Hostile, aggressive family conflict trajectories during the transition to adulthood: Associations with adolescent Big Five and emerging adulthood adjustment problems. Journal of Adolescence, Vol. 37, Issue. 5, p. 647.

    Demyttenaere, Koen Desaiah, Durisala Petit, Claude Croenlein, Jens and Brecht, Stephan 2012. Time course of improvement of different symptom clusters in patients with major depression and pain treated with duloxetine or placebo. Current Medical Research and Opinion, Vol. 28, Issue. 1, p. 41.

    Luengo Kanacri, Bernadette P. Pastorelli, Concetta Zuffianò, Antonio Eisenberg, Nancy Ceravolo, Rosalba and Caprara, Gian Vittorio 2014. Trajectories of prosocial behaviors conducive to civic outcomes during the transition to adulthood: The predictive role of family dynamics. Journal of Adolescence, Vol. 37, Issue. 8, p. 1529.

    Zhu, Lei Ranchor, Adelita V. van der Lee, Marije Garssen, Bert Sanderman, Robbert and Schroevers, Maya J. 2016. Subtypes of depression in cancer patients: an empirically driven approach. Supportive Care in Cancer, Vol. 24, Issue. 3, p. 1387.

    Melchior, Hanne Schulz, Holger Kriston, Levente Hergert, Anika Hofreuter-Gätgens, Kerstin Bergelt, Corinna Morfeld, Matthias Koch, Uwe and Watzke, Birgit 2016. Symptom change trajectories during inpatient psychotherapy in routine care and their associations with long-term outcomes. Psychiatry Research, Vol. 238, p. 228.


Trajectories of change in depression severity during treatment with antidepressants

  • R. Uher (a1), B. Muthén (a2), D. Souery (a3), O. Mors (a4), J. Jaracz (a5), A. Placentino (a6), A. Petrovic (a7), A. Zobel (a8), N. Henigsberg (a9), M. Rietschel (a10), K. J. Aitchison (a1), A. Farmer (a1) and P. McGuffin (a1)
  • DOI:
  • Published online: 29 October 2009

Response and remission defined by cut-off values on the last observed depression severity score are commonly used as outcome criteria in clinical trials, but ignore the time course of symptomatic change and may lead to inefficient analyses. We explore alternative categorization of outcome by naturally occurring trajectories of symptom change.


Growth mixture models were applied to repeated measurements of depression severity in 807 participants with major depression treated for 12 weeks with escitalopram or nortriptyline in the part-randomized Genome-based Therapeutic Drugs for Depression study. Latent trajectory classes were validated as outcomes in drug efficacy comparison and pharmacogenetic analyses.


The final two-piece growth mixture model categorized participants into a majority (75%) following a gradual improvement trajectory and the remainder following a trajectory with rapid initial improvement. The rapid improvement trajectory was over-represented among nortriptyline-treated participants and showed an antidepressant-specific pattern of pharmacogenetic associations. In contrast, conventional response and remission favoured escitalopram and produced chance results in pharmacogenetic analyses. Controlling for drop-out reduced drug differences on response and remission but did not affect latent trajectory results.


Latent trajectory mixture models capture heterogeneity in the development of clinical response after the initiation of antidepressants and provide an outcome that is distinct from traditional endpoint measures. It differentiates between antidepressants with different modes of action and is robust against bias due to differential discontinuation.

Corresponding author
*Address for correspondence: Dr R. Uher, Medical Research Council (MRC) Social, Genetic and Developmental Psychiatry Research Centre, Institute of Psychiatry, King's College London, UK (Email:
Linked references
Hide All

This list contains references from the content that can be linked to their source. For a full set of references and notes please see the PDF or HTML where available.

B Bandelow , DS Baldwin , OT Dolberg , HF Andersen , DJ Stein (2006). What is the threshold for symptomatic response and remission for major depressive disorder, panic disorder, social anxiety disorder, and generalized anxiety disorder? Journal of Clinical Psychiatry 67, 14281434.

P Bech , P Allerup , N Reisby , LF Gram (1984). Assessment of symptom change from improvement curves on the Hamilton depression scale in trials with antidepressants. Psychopharmacology (Berlin) 84, 276281.

AT Beck , CH Ward , M Mendelson , J Mock , J Erbaugh (1961). An inventory for measuring depression. Archives of General Psychiatry 4, 561571.

C Beunckens , G Molenberghs , G Verbeke , C Mallinckrodt (2008). A latent-class mixture model for incomplete longitudinal Gaussian data. Biometrics 64, 96105.

TJ Carmody , AJ Rush , I Bernstein , D Warden , S Brannan , D Burnham , A Woo , MH Trivedi (2006). The Montgomery Asberg and the Hamilton ratings of depression: a comparison of measures. European Neuropsychopharmacology 16, 601611.

J Cohen (1960). A coefficient of agreement for nominal scales. Educational and Psychological Measurement 20, 3746.

E Fahndrich (1984). The arbitrariness of response definition in clinical trials with antidepressants. Pharmacopsychiatry 17, 107108.

E Frank , RF Prien , RB Jarrett , MB Keller , DJ Kupfer , PW Lavori , AJ Rush , MM Weissman (1991). Conceptualization and rationale for consensus definitions of terms in major depressive disorder. Remission, recovery, relapse, and recurrence. Archives of General Psychiatry 48, 851855.

R Gueorguieva , JH Krystal (2004). Move over ANOVA: progress in analyzing repeated-measures data and its reflection in papers published in the Archives of General Psychiatry. Archives of General Psychiatry 61, 310317.

M Hamilton (1967). Development of a rating scale for primary depressive illness. British Journal of Clinical Psychology 6, 278296.

PR Joyce , RT Mulder , SE Luty , PF Sullivan , JM McKenzie , RM Abbott , IF Stevens (2002). Patterns and predictors of remission, response and recovery in major depression treated with fluoxetine or nortriptyline. Australian and New Zealand Journal of Psychiatry 36, 384391.

P Lane (2008). Handling drop-out in longitudinal clinical trials: a comparison of the LOCF and MMRM approaches. Pharmaceutical Statistics 7, 93106.

S Leucht , S Heres , J Hamann , JM Kane (2008). Methodological issues in current antipsychotic drug trials. Schizophrenia Bulletin 34, 275285.

CH Mallinckrodt , WS Clark , SR David (2001). Accounting for dropout bias using mixed-effects models. Journal of Biopharmaceutical Statistics 11, 921.

SA Montgomery (1994). Clinically relevant effect sizes in depression. European Neuropsychopharmacology 4, 283284.

SA Montgomery , M Asberg (1979). A new depression scale designed to be sensitive to change. British Journal of Psychiatry 134, 382389.

RT Mulder , PR Joyce , C Frampton (2003). Relationships among measures of treatment outcome in depressed patients. Journal of Affective Disorders 76, 127135.

GI Papakostas , CM Crawford , MJ Scalia , M Fava (2007). Timing of clinical improvement and symptom resolution in the treatment of major depressive disorder. A replication of findings with the use of a double-blind, placebo-controlled trial of Hypericum perforatum versus fluoxetine. Neuropsychobiology 56, 132137.

G Parker (2009). Antidepressants on trial: how valid is the evidence? British Journal of Psychiatry 194, 13.

RF Prien , LL Carpenter , DJ Kupfer (1991). The definition and operational criteria for treatment outcome of major depressive disorder. A review of the current research literature. Archives of General Psychiatry 48, 796800.

FM Quitkin , JG Rabkin , D Ross , JW Stewart (1984). Identification of true drug response to antidepressants. Use of pattern analysis. Archives of General Psychiatry 41, 782786.

M Rietschel , JL Kennedy , F Macciardi , HY Meltzer (1999). Application of pharmacogenetics to psychotic disorders: the first consensus conference. The Consensus Group for Outcome Measures in Psychoses for Pharmacological Studies. Schizophrenia Research 37, 191196.

P Royston , DG Altman , W Sauerbrei (2006). Dichotomizing continuous predictors in multiple regression: a bad idea. Statistics in Medicine 25, 127141.

HH Stassen , J Angst , D Hell , C Scharfetter , A Szegedi (2007). Is there a common resilience mechanism underlying antidepressant drug response? Evidence from 2848 patients. Journal of Clinical Psychiatry 68, 11951205.

A Szegedi , WT Jansen , AP Pv Willigenburg , ME van der , HH Stassen , ME Thase (2009). Early improvement in the first 2 weeks as a predictor of treatment outcome in patients with major depressive disorder: a meta-analysis including 6562 patients. Journal of Clinical Psychiatry 70, 344353.

A Szegedi , MJ Muller , I Anghelescu , C Klawe , R Kohnen , O Benkert (2003). Early improvement under mirtazapine and paroxetine predicts later stable response and remission with high sensitivity in patients with major depression. Journal of Clinical Psychiatry 64, 413420.

MJ Taylor , N Freemantle , JR Geddes , Z Bhagwagar (2006). Early onset of selective serotonin reuptake inhibitor antidepressant action: systematic review and meta-analysis. Archives of General Psychiatry 63, 12171223.

R Uher (2008). The implications of gene-environment interactions in depression: will cause inform cure? Molecular Psychiatry 13, 10701078.

R Uher , P Huezo-Diaz , N Perroud , R Smith , M Rietschel , O Mors , J Hauser , W Maier , D Kozel , N Henigsberg , M Barreto , A Placentino , MZ Dernovsek , T Schulze , P Kalember , A Zobel , P Czerski , ER Larsen , D Souery , C Govannini , JM Gray , CM Lewis , A Farmer , KJ Aitchison , P McGuffin , I Craig (2009 a). Genetic predictors of antidepressant response in the GENDEP project. Pharmacogenomics Journal 9, 225233.

R Uher , W Maier , J Hauser , A Marusic , C Schmael , O Mors , N Henigsberg , D Souery , A Placentino , M Rietschel , A Zobel , M Dmitrzak-Weglarz , A Petrovic , L Jorgensen , P Kalember , C Govannini , M Barreto , A Elkin , S Landau , A Farmer , KJ Aitchison , P McGuffin (2009 b). Differential efficacy of escitalopram and nortriptyline on dimensional measures of depression in the GENDEP project. British Journal of Psychiatry 194, 252259.

JP Vandenbroucke (2008). Observational research, randomised trials, and two views of medical science. PLoS Medicine 5, e67.

M Zimmerman , MA Posternak , I Chelminski (2004). Derivation of a definition of remission on the Montgomery-Asberg depression rating scale corresponding to the definition of remission on the Hamilton rating scale for depression. Journal of Psychiatric Research 38, 577582.

Recommend this journal

Email your librarian or administrator to recommend adding this journal to your organisation's collection.

Psychological Medicine
  • ISSN: 0033-2917
  • EISSN: 1469-8978
  • URL: /core/journals/psychological-medicine
Please enter your name
Please enter a valid email address
Who would you like to send this to? *


Type Description Title
Supplementary Materials

Uher supplementary material

 Unknown (848 KB)
848 KB